Ketotifeno [INN-Spanish] en es it fr

Ketotifeno [INN-Spanish] Brand names, Ketotifeno [INN-Spanish] Analogs

Ketotifeno [INN-Spanish] Brand Names Mixture

  • No information avaliable

Ketotifeno [INN-Spanish] Chemical_Formula


Ketotifeno [INN-Spanish] RX_link

Ketotifeno [INN-Spanish] fda sheet

Ketotifeno_[INN-Spanish] FDA

Ketotifeno [INN-Spanish] msds (material safety sheet)

Ketotifeno_[INN-Spanish] MSDS

Ketotifeno [INN-Spanish] Synthesis Reference

No information avaliable

Ketotifeno [INN-Spanish] Molecular Weight

204.292 g/mol

Ketotifeno [INN-Spanish] Melting Point

264-265 oC

Ketotifeno [INN-Spanish] H2O Solubility

210 mg/mL

Ketotifeno [INN-Spanish] State


Ketotifeno [INN-Spanish] LogP


Ketotifeno [INN-Spanish] Dosage Forms


Ketotifeno [INN-Spanish] Indication

For adjuvant treatment in combination with fluorouracil after surgical resection in patients with Dukes' stage C colon cancer. Also used to treat malignant melanoma and head/neck cancer.

Ketotifeno [INN-Spanish] Pharmacology

Levamisole is a synthetic imidazothiazole derivative that has been widely used in treatment of worm infestations in both humans and animals. As an anthelmintic, it probably works by targeting the nematode nicotinergic acetylcholine receptor. As an immunomodulator, it appears that Levamisole is an immunostimulant which has been shown to increase NK cells and activated T-cells in patients receiving this adjuvantly along with 5FU for Stage III colon cancer.

Ketotifeno [INN-Spanish] Absorption

Levamisole is rapidly absorbed (2 hours) from the gastrointestinal tract.

Ketotifeno [INN-Spanish] side effects and Toxicity

LD50 = 40 mg/kg (Pigs, subcutaneous); LD50 = 180 mg/kg (rat, oral)

Ketotifeno [INN-Spanish] Patient Information

Ketotifeno [INN-Spanish] Organisms Affected

Humans and other mammals